These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 32024555

  • 1. CD73 sustained cancer-stem-cell traits by promoting SOX9 expression and stability in hepatocellular carcinoma.
    Ma XL, Hu B, Tang WG, Xie SH, Ren N, Guo L, Lu RQ.
    J Hematol Oncol; 2020 Feb 05; 13(1):11. PubMed ID: 32024555
    [Abstract] [Full Text] [Related]

  • 2. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis.
    Ma XL, Shen MN, Hu B, Wang BL, Yang WJ, Lv LH, Wang H, Zhou Y, Jin AL, Sun YF, Zhang CY, Qiu SJ, Pan BS, Zhou J, Fan J, Yang XR, Guo W.
    J Hematol Oncol; 2019 Apr 11; 12(1):37. PubMed ID: 30971294
    [Abstract] [Full Text] [Related]

  • 3. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
    Li B, Liu D, Yang P, Li HY, Wang D.
    Gene; 2019 Jul 30; 707():78-85. PubMed ID: 31075412
    [Abstract] [Full Text] [Related]

  • 4. Incomplete radiofrequency ablation promotes the development of CD133+ cancer stem cells in hepatocellular carcinoma cell line HepG2 via inducing SOX9 expression.
    Yuan CW, Wang ZC, Liu K, Liu DJ.
    Hepatobiliary Pancreat Dis Int; 2018 Oct 30; 17(5):416-422. PubMed ID: 30262419
    [Abstract] [Full Text] [Related]

  • 5. PAF enhances cancer stem cell properties via β-catenin signaling in hepatocellular carcinoma.
    Li M, Mu XD, Song JR, Zhai PT, Cheng Y, Le Y, Li ZB.
    Cell Cycle; 2021 May 30; 20(10):1010-1020. PubMed ID: 33970778
    [Abstract] [Full Text] [Related]

  • 6. IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.
    Huang WC, Tung SL, Chen YL, Chen PM, Chu PY.
    BMC Cancer; 2018 May 30; 18(1):609. PubMed ID: 29848298
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA DUXAP9 promotes hepatocellular carcinoma cell stemness via directly interacting with sox9.
    Zeng R, Wang C, Wang W, Wang S.
    Environ Toxicol; 2021 Sep 30; 36(9):1793-1801. PubMed ID: 34086387
    [Abstract] [Full Text] [Related]

  • 8. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 9. COLEC10 inhibits the stemness of hepatocellular carcinoma by suppressing the activity of β-catenin signaling.
    Cai MN, Chen DM, Chen XR, Gu YR, Liao CH, Xiao LX, Wang JL, Lin BL, Huang YH, Lian YF.
    Cell Oncol (Dordr); 2024 Oct 29; 47(5):1897-1910. PubMed ID: 39080215
    [Abstract] [Full Text] [Related]

  • 10. Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target.
    Ma XL, Sun YF, Wang BL, Shen MN, Zhou Y, Chen JW, Hu B, Gong ZJ, Zhang X, Cao Y, Pan BS, Zhou J, Fan J, Guo W, Yang XR.
    BMC Cancer; 2019 Aug 01; 19(1):760. PubMed ID: 31370822
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
    Huan HB, Yang DP, Wen XD, Chen XJ, Zhang L, Wu LL, Bie P, Xia F.
    J Exp Clin Cancer Res; 2017 Jun 24; 36(1):86. PubMed ID: 28646927
    [Abstract] [Full Text] [Related]

  • 14. miR-589-5p inhibits MAP3K8 and suppresses CD90+ cancer stem cells in hepatocellular carcinoma.
    Zhang X, Jiang P, Shuai L, Chen K, Li Z, Zhang Y, Jiang Y, Li X.
    J Exp Clin Cancer Res; 2016 Nov 11; 35(1):176. PubMed ID: 27835990
    [Abstract] [Full Text] [Related]

  • 15. Interaction of lncRNA-MALAT1 and miR-124 regulates HBx-induced cancer stem cell properties in HepG2 through PI3K/Akt signaling.
    He B, Peng F, Li W, Jiang Y.
    J Cell Biochem; 2019 Mar 11; 120(3):2908-2918. PubMed ID: 30500989
    [Abstract] [Full Text] [Related]

  • 16. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X, Zheng F, Li Y, Hao J, Tang Z, Tian C, Yang Q, Zhu T, Diao C, Zhang C, Chen M, Hu S, Guo P, Zhang L, Liao Y, Yu W, Chen M, Zou L, Guo W, Deng W.
    Redox Biol; 2019 Jan 11; 20():427-441. PubMed ID: 30419422
    [Abstract] [Full Text] [Related]

  • 17. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
    Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W, Jiang X, Li H, Yang P, Xiang D.
    Gastroenterology; 2023 May 11; 164(6):990-1005. PubMed ID: 36764493
    [Abstract] [Full Text] [Related]

  • 18. SOX9 is a novel cancer stem cell marker surrogated by osteopontin in human hepatocellular carcinoma.
    Kawai T, Yasuchika K, Ishii T, Miyauchi Y, Kojima H, Yamaoka R, Katayama H, Yoshitoshi EY, Ogiso S, Kita S, Yasuda K, Fukumitsu K, Komori J, Hatano E, Kawaguchi Y, Uemoto S.
    Sci Rep; 2016 Jul 26; 6():30489. PubMed ID: 27457505
    [Abstract] [Full Text] [Related]

  • 19. SOX9 is a proliferation and stem cell factor in hepatocellular carcinoma and possess widespread prognostic significance in different cancer types.
    Richtig G, Aigelsreiter A, Schwarzenbacher D, Ress AL, Adiprasito JB, Stiegelbauer V, Hoefler G, Schauer S, Kiesslich T, Kornprat P, Winder T, Eisner F, Gerger A, Stoeger H, Stauber R, Lackner C, Pichler M.
    PLoS One; 2017 Jul 26; 12(11):e0187814. PubMed ID: 29121666
    [Abstract] [Full Text] [Related]

  • 20. lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
    Yang C, Cai WC, Dong ZT, Guo JW, Zhao YJ, Sui CJ, Yang JM.
    Gene; 2019 Mar 01; 687():73-81. PubMed ID: 30391438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.